News Focus
News Focus
Followers 2424
Posts 92347
Boards Moderated 1
Alias Born 09/12/2003

Re: None

Sunday, 11/17/2024 5:26:40 PM

Sunday, November 17, 2024 5:26:40 PM

Post# of 23350
As shareholders striving to support the stock, it's frustrating to see some people steering discussions in the wrong direction. Let me clarify once again: I am neither a pumper nor a basher. I share my opinions here so we can collectively analyze and discern the truth.

Regarding the Loan Agreement with Invenire Capital, LP, it's critical for everyone to read and comprehend the filings. Unfortunately, some are either clueless and misunderstand the documents or intentionally spread misinformation to create panic and encourage others to sell their shares. This kind of behavior spreading inaccurate or misleading information is manipulative and unethical.

For those still unclear, let me break this down:

On April 28, 2023, the company issued 10,000,000 restricted common shares to Valerian Capital to restructure debt. Instead of repaying the debt in cash, the company settled it through equity issuance. This likely aimed to reduce liabilities and enhance liquidity, preserving cash flow for other needs.

Here’s another key point that needs attention:

The interest accrued reported as $0 for the convertible note with Invenire Capital likely means no interest was charged or accumulated at the time of reporting 10-Q end June 30, 2024 despite the 10% annual interest rate stated in the agreement. Why?

The note’s maturity date is September 8, 2023. If the note had not been paid off, the interest would typically start accruing and be reported after maturity.

The $0 interest accrued indicated the note was paid off early. If the company repaid the $2,480,000 principal before the maturity date, interest would not have had time to accrue or could have been settled as part of the repayment.

Early repayment also results in no interest being recorded if the company does not allow for the interest to accrue.

The restricted shares (over 500 million) remain unchanged and are clearly held by insiders or institutional investors, and institutional investors are still holding shares strongly, this provides they still have confidence in the company future growth potential.

This context is important to understand before jumping to conclusions or spreading misinformation. Let’s focus on facts and avoid the panic-driven narratives that only hurt shareholders and the company.

On September 8, 2022 the Company executed a Convertible Loan Agreement with Invenire
Capital, LP. The Company received a total of $2,395,000 net of legal and professional fees. The
Company will owe $2,640,000 on the maturity date.

On April 28, 2023 Valerian Capital was issued 10,000,000 shares of restricted common stock for
debt restructuring.


https://www.otcmarkets.com/otcapi/company/financial-report/410157/content


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y